Related Experiment Video
Updated: Jun 13, 2026
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide
Bin Xing1, Tao Xin, Lingling Zhao
1Department of Anatomy & Neurobiology, University of Kentucky, Lexington, KY 40536, USA. bin.xing@UTSouthwestern.edu
Abstract:
Aberrant microglia activation causes dopaminergic neuronal loss and nitric oxide produced by microglia plays a critical role in dopaminergic neuronal degeneration. However, no study has determined if GDNF protects dopaminergic neurons via inhibiting nitric oxide generation in Parkinson's disease animal model. We report that GDNF not only reduces lipopolysaccharide-induced degeneration of dopaminergic neurons, suppresses microglia activation and nitric oxide generation, but also reverses the inhibition of phosphoinositide 3-kinase (PI3K) in dopaminergic neurons and microglia. It suggests that the neuroprotective effect of GDNF on dopaminergic neurons may be related to its suppression of microglia activation-mediated nitric oxide via releasing the inhibition of PI3K in both neurons and microglia.
Insights
Glial cell-derived neurotrophic factor (GDNF) protects dopamine neurons in Parkinson's disease models by reducing nitric oxide and activating phosphoinositide 3-kinase (PI3K). This discovery offers new therapeutic insights for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Neuroimmunology
- Pharmacology
Background:
- Aberrant microglia activation contributes to dopaminergic neuronal loss in Parkinson's disease.
- Microglia-derived nitric oxide is implicated in dopaminergic neurodegeneration.
- The protective role of GDNF against nitric oxide in Parkinson's disease models is not fully understood.
Purpose of the Study:
- To investigate whether GDNF protects dopaminergic neurons by inhibiting nitric oxide generation in a Parkinson's disease animal model.
- To explore the effect of GDNF on microglia activation and nitric oxide production.
- To examine the impact of GDNF on phosphoinositide 3-kinase (PI3K) signaling in neurons and microglia.
Main Methods:
- Utilized a lipopolysaccharide-induced Parkinson's disease animal model.
- Administered GDNF to assess its effects on dopaminergic neuron survival.
- Measured microglia activation, nitric oxide generation, and PI3K pathway activity.
Main Results:
- GDNF significantly reduced lipopolysaccharide-induced dopaminergic neuron degeneration.
- GDNF suppressed microglia activation and nitric oxide generation.
- GDNF reversed the inhibition of PI3K in both dopaminergic neurons and microglia.
Conclusions:
- GDNF exhibits neuroprotective effects on dopaminergic neurons in a Parkinson's disease model.
- GDNF's neuroprotection is associated with the suppression of microglia activation and nitric oxide production.
- The mechanism involves the release of PI3K inhibition in neurons and microglia, suggesting a novel therapeutic pathway.
